Redeye updates its estimates and fair value range following Arise’s Q4 2024 report, which marked the end of a challenging year for the sector. We think Arise managed the market environment well, thanks to favourable price hedges, ongoing constructions being managed well, and a 40MW BESS project being divested. Arise’s implicit financial target is to divest >360MW in 2025, which is well-supported by its project portfolio. If successful, this would make 2025 the second-best year in Arise’s history, according to our estimates.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/